Based on our obtained data, we would like to clarify that we do not recommend routine testing of NT-proBNP among all ambulatory patients with PAD; however, we wanted to demonstrate that the levels of NT-proBNP are significantly elevated in ambulatory patients with PAD (especially advanced PAD). The gene discussed is NPPB; the disease is peripheral arterial disease.